Other bone disorders include a group of metabolic, structural, and secondary conditions that affect bone strength, mineral balance, or integrity but are distinct from osteoporosis. These conditions may be related to endocrine disease, kidney dysfunction, genetic disorders, or cancer involvement of the bone.
At the Saint John’s Cancer Institute Center for Endocrine Tumors and Disorders, our specialists evaluate complex bone disorders using advanced laboratory testing, imaging, and coordinated multidisciplinary care.
What Are Other, Non-Osteoporosis Bone Disorders?
Other bone disorders refer to less common conditions that disrupt normal bone formation, remodeling, or mineralization. Unlike osteoporosis—which primarily involves loss of bone density—these disorders may affect bone structure, mineral balance, or the way bone tissue is built and repaired. Many are closely linked to endocrine, metabolic, renal, or oncologic processes, making accurate diagnosis essential for effective treatment.
How These Disorders Affect Bone Health
These conditions may alter the shape, strength, or mineral content of bone, leading to pain, deformity, or increased fracture risk. Some disorders interfere with calcium or phosphate regulation, while others affect the way bone cells remodel tissue. Understanding the underlying cause helps guide treatment and long‑term monitoring.
Why Specialized Evaluation Matters
Because many bone disorders overlap with endocrine or metabolic conditions, evaluation by an endocrine specialist is often necessary. Our team works closely with nephrology, oncology, and genetics when needed to ensure a complete and accurate diagnosis.
Types of Bone Disorders We Evaluate
A variety of metabolic and structural bone disorders fall under this category. Each condition affects bone differently and requires a tailored approach to diagnosis and treatment. Below are some of the most common disorders evaluated by our endocrine team.
Osteomalacia
Osteomalacia occurs when bones fail to mineralize properly, often due to vitamin D deficiency, malabsorption, or chronic kidney disease. This leads to soft, weakened bones that may cause pain, muscle weakness, or fractures. Treatment focuses on correcting the underlying deficiency or metabolic imbalance.
Paget’s Disease of Bone
Paget’s disease is a chronic condition in which bone remodeling occurs too rapidly, producing enlarged but structurally weak bone. It most commonly affects the spine, pelvis, skull, and long bones. Early diagnosis and treatment can help prevent complications such as fractures or arthritis.
Renal Osteodystrophy
Renal osteodystrophy is a bone disorder related to chronic kidney disease, caused by imbalances in calcium, phosphorus, and parathyroid hormone (PTH). Because it is closely tied to endocrine function, evaluation often includes assessment of parathyroid disease and mineral metabolism.
Hypophosphatemia
Hypophosphatemia is characterized by low phosphate levels, which can impair bone strength and lead to fractures or bone pain. It may be inherited or acquired and often requires specialized metabolic evaluation to determine the cause.
Osteoporosis
Osteoporosis develops due to a combination of biological, hormonal, and lifestyle factors. See Osteoporosis for additional information.
Bone Metastases from Cancer
Bone metastases occur when cancer spreads from its original site to the bone. Although not a primary bone disorder, metastases can mimic metabolic bone disease on imaging or laboratory testing. Breast, prostate, lung, kidney, and thyroid cancers are among the most common sources of bone metastases.
How Bone Metastases Affect Bone Health
When cancer cells spread to bone, they can weaken the bone structure and increase the risk of fractures. Patients may experience bone pain, spinal cord compression, or elevated calcium levels. These complications require prompt evaluation and coordinated care.
- Bone pain
- Fractures
- Spinal cord compression
- Elevated calcium levels
Coordinated Care With Oncology
Because bone metastases can resemble metabolic bone disorders, endocrine specialists often collaborate with oncology teams to evaluate bone health, manage calcium abnormalities, and reduce fracture risk. This multidisciplinary approach ensures comprehensive care for patients with cancer‑related bone involvement.
Fibrous Dysplasia
Fibrous dysplasia is a rare bone disorder in which normal bone is replaced with fibrous tissue, leading to weakened bone structure and potential deformity. It may involve a single bone (monostotic) or multiple bones (polyostotic) and can be associated with endocrine abnormalities in certain syndromic forms.
Symptoms of Fibrous Dysplasia
Symptoms vary depending on the bones involved and may include pain, fractures, deformity, or limb length differences. Some individuals have mild disease, while others require long‑term monitoring and supportive care.
- Bone pain
- Fractures
- Bone deformity
- Limb length differences
How It Is Managed
Management focuses on monitoring bone integrity, reducing symptoms, and addressing associated hormonal conditions when present. Our endocrine team evaluates for related disorders and coordinates care with orthopedics and genetics when needed.
Signs and Symptoms of Bone Disorders
Bone disorders can present in many ways depending on the underlying cause and severity. Some individuals experience noticeable symptoms, while others are diagnosed after abnormal imaging or laboratory findings. Recognizing early signs can help prevent complications.
Common Symptoms
Symptoms may include persistent bone pain, recurrent fractures, muscle weakness, or skeletal deformities. Children and adolescents may experience delayed growth or difficulty walking. Any unexplained bone symptoms should prompt evaluation.
- Persistent bone pain or tenderness
- Recurrent or unexplained fractures
- Muscle weakness
- Skeletal deformities
- Loss of height
- Difficulty walking
- Delayed growth in children or adolescents
Causes and Risk Factors
Bone disorders may arise from hormonal imbalances, metabolic abnormalities, chronic disease, or genetic factors. Identifying the underlying cause is essential for selecting the appropriate treatment strategy. Many conditions require evaluation by an endocrine specialist.
Common Causes
Hormonal disorders involving the thyroid, parathyroid, or adrenal glands can significantly affect bone health. Chronic kidney disease, vitamin D or calcium deficiency, and long‑term steroid use are also common contributors. Some disorders are inherited or related to cancer or cancer treatment.
- Hormonal imbalances (thyroid, parathyroid, adrenal)
- Chronic kidney disease
- Vitamin D or calcium deficiency
- Genetic conditions
- Long‑term steroid use
- Cancer or cancer treatment
- Malabsorption disorders
How Bone Disorders Are Diagnosed
Diagnosis typically involves a comprehensive endocrine and metabolic evaluation. Our team uses laboratory testing, imaging, and specialized studies to determine the cause of bone abnormalities and guide treatment. Early diagnosis helps prevent complications and supports long‑term bone health.
Laboratory Testing
Blood and urine tests help identify abnormalities in calcium, phosphorus, vitamin D, and parathyroid hormone (PTH). Kidney function and bone turnover markers may also be evaluated. These tests help determine whether endocrine or metabolic factors are contributing to bone disease.
- Calcium and phosphorus levels
- Vitamin D levels
- Parathyroid hormone (PTH)
- Kidney function tests
- Bone turnover markers
Imaging
Imaging studies help assess bone structure, density, and integrity. Depending on the condition, evaluation may include DEXA scans, X‑rays, CT, or MRI. These tools help identify fractures, deformities, or abnormal bone remodeling.
- Bone density testing (DEXA)
- X‑rays
- CT or MRI when indicated
Specialized Evaluation
In select cases, genetic testing or advanced metabolic studies may be recommended. These evaluations help diagnose rare or inherited bone disorders and guide personalized treatment plans.
Treatment and Management
Treatment depends on the specific disorder and its underlying cause. Our team develops individualized care plans that may include nutritional support, medication, hormonal therapy, or management of related endocrine or kidney disease. Long‑term monitoring helps ensure treatment remains effective over time.
Treatment Options
Management may involve correcting vitamin or mineral deficiencies, regulating hormone levels, or using medications that influence bone remodeling. When bone disease is related to endocrine or kidney conditions, treating the underlying disorder is essential for improving bone health.
- Vitamin or mineral supplementation
- Hormonal therapy
- Medications that regulate bone remodeling
- Management of endocrine or kidney disease
- Long‑term monitoring of bone density and labs
When to See a Specialist
Evaluation by an endocrine specialist is recommended when bone symptoms are unexplained, recurrent, or associated with abnormal laboratory findings. Early assessment helps prevent complications and ensures appropriate treatment.
Signs You May Need Evaluation
You should consider seeing a specialist if you experience recurrent fractures, persistent bone pain, or abnormal calcium or phosphate levels. Individuals with endocrine or kidney‑related bone disease may also benefit from specialized care.
- Recurrent fractures
- Persistent or unexplained bone pain
- Abnormal calcium or phosphate levels
- Bone disease related to endocrine or kidney conditions
- A rare or unclear bone diagnosis
Frequently Asked Questions
Patients often have questions about how these disorders differ from osteoporosis, how they are treated, and when to seek care. Below are answers to some of the most common concerns.
Are these bone disorders the same as osteoporosis?
No. Osteoporosis affects bone density, while other bone disorders may involve bone structure, mineralization, or metabolism. Each condition requires a different diagnostic and treatment approach.
Can these bone disorders be treated?
Many bone disorders can be effectively managed once the underlying cause is identified. Treatment may include medication, nutritional support, or management of endocrine or kidney disease.
Do bone metastases require endocrine care?
Endocrinology may be involved in managing bone health, calcium levels, and fracture risk in coordination with oncology teams. This collaborative approach helps support overall bone stability and metabolic balance.
Is fibrous dysplasia inherited?
Most cases are sporadic and not inherited, though some forms are associated with endocrine syndromes. Genetic evaluation may be recommended in select cases.
Get Answers to Your Questions
The Endocrine Center of Excellence provides expert evaluation and long‑term management for complex bone disorders. Our team works closely with specialists across Saint John’s Health Center to ensure comprehensive, compassionate care for every patient.
If you have questions regarding bone disorders, symptoms, or treatment, please call today. Click here to request an appointment.
